Market TodayThemes and Stocks SummaryThematic Stock SearchDaily Refresh Schedule
URGN - UroGen Pharma Ltd
0.94(4.97%)9:00:00 PM 3/5/2021
UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing solutions for specialty cancers and urologic diseases. The company's lead product candidates are UGN-101 and UGN-102, which are designed to ablate tumors by non-surgical means and to treat several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-201, a proprietary immunotherapy product candidate for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; and Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery. UroGen Pharma Ltd. was founded in 2004 and is based in Princeton, New Jersey.
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 


Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.


  • Volatility is at a recent 2 week high. A high volatility of stock movement indicates uncertainty.
Stock Statistics
PE Ratio
PEG Ratio
P/S (ttm)109.8
Earning Growth (QoQ)
Revenue Growth (QoQ)
Short %15%
Held by Institutions %75%
1 Day Vol Adjusted Return1.0
1 Month Vol Adjusted Return-1.7
3 Month Vol Adjusted Return-0.1
6 Month Vol Adjusted Return-0.9
20 Days SMA Price ZScore-1.1
50 Days SMA Price ZScore-0.7
12 -26 Days PPO-3.7
1 Month Average Short Volume Ratio47.3
1 Day Volume Change ZScore1.6
1 Month Daily Vol5.0
Related Topics
leak data

Related Topics


Related Peers

Stock news